Erythrina mulungu Alkaloids Are Potent Inhibitors of Neuronal Nicotinic Receptor Currents in Mammalian Cells
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Crude extracts and three isolated alkaloids from Erythrina mulungu plants have shown anxiolytic effects in different animal models. We investigated whether these alkaloids could affect nicotinic acetylcholine receptors and if they are selective for different central nervous system (CNS) subtypes. Screening experiments were performed using a single concentration of the alkaloid co-applied with acetylcholine in whole cell patch-clamp recordings in three different cell models: (i) PC12 cells natively expressing α3* nicotinic acetylcholine receptors; (ii) cultured hippocampal neurons natively expressing α7* nicotinic acetylcholine receptors; and (iii) HEK 293 cells heterologoulsy expressing α4β2 nicotinic acetylcholine receptors. For all three receptors, the percent inhibition of acetylcholine-activated currents by (+)-11á-hydroxyerysotrine was the lowest, whereas (+)-erythravine and (+)-11á-hydroxyerythravine inhibited the currents to a greater extent. For the latter two substances, we obtained concentration-response curves with a pre-application protocol for the α7* and α4β2 nicotinic acetylcholine receptors. The IC50 obtained with (+)-erythravine and (+)-11á-hydroxyerythravine were 6 µM and 5 µM for the α7* receptors, and 13 nM and 4 nM for the α4β2 receptors, respectively. Our data suggest that these Erythrina alkaloids may exert their behavioral effects through inhibition of CNS nicotinic acetylcholine receptors, particularly the α4β2 subtype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mineur, Y. S., Obayemi, A., Wigestrand, M. B., Fote, G. M., Calarco, C. A., Li, A. M., & Picciotto, M. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219731110 · Cited by 375 · cited 1×
“The actual mechanism by which nicotinic acetylcholine receptors affect anxiety is controversial but available evidence suggests the involvement of 5-hydroxytryptamine receptors [14,34].”
BackgroundMcGranahan, T. M., Patzlaff, N. E., Grady, S. R., Heinemann, S. F., & Booker, T. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0937-11.2011 · Cited by 165
Nicotinic–serotonergic interactions in brain and behaviour
Seth, P., Cheeta, S., Tucci, S., & File, S. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00715-8 · Cited by 145
Altered Anxiety-Related Responses in Mutant Mice Lacking the β4 Subunit of the Nicotinic Receptor
Salas, R., Pieri, F., Fung, B., Dani, J. A., & De Biasi, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06255.2003 · Cited by 128 · cited 1×
“receptor function, present enhanced anxiety-related behavior [40] and knockouts for the b3 [41] and b4 [42] nicotinic acetylcholine”
BackgroundBacher, I., Wu, B., Shytle, D. R., & George, T. P. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903329102 · Cited by 96 · cited 1×
“unresponsive to citalopram alone [43,44], However, its develop-”
BackgroundMarks, M. J., Whiteaker, P., Calcaterra, J., Stitzel, J. A., Bullock, A. E., Grady, S. R., Picciotto, M. R., Changeux, J.-P., & Collins, A. C. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38240-0 · Cited by 79
Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice
Booker, T. K., Butt, C. M., Wehner, J. M., Heinemann, S. F., & Collins, A. C. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.04.011 · Cited by 49
Research works printed but not linked: 35
- GM Onusic, 2002, Effect of acute treatment with a water-alcohol extract of Erythrina mulungu on anxiety-related responses in rats, Braz J Med Biol Res, 35, 473, 10.1590/S0100-879X2002000400011 · doi:10.1590/s0100-879x2002000400011
- GM Onusic, 2003, Effects of chronic treatment with a water-alcohol extract from Erythrina mulungu on anxiety-related responses in rats, Biol Pharm Bull, 26, 1538, 10.1248/bpb.26.1538 · doi:10.1248/bpb.26.1538
- SMM Vasconcelos, 2003, Antinociceptive activities of the hydroalcoholic extracts from Erythrina velutina and Erythrina mulungu in mice, Biol Pharm Bull, 26, 946, 10.1248/bpb.26.946 · doi:10.1248/bpb.26.946
- SMM Vasconcelos, 2007, Anticonvulsant activity of hydroalcoholic extracts from Erythrina velutina and Erythrina mulungu, J Ethnopharmacol, 110, 271, 10.1016/j.jep.2006.09.023 · doi:10.1016/j.jep.2006.09.023
- SA Faggion, 2011, Anticonvulsant profile of the alkaloids (+)-erythravine and (+)-11-alpha-hydroxy-erythravine isolated from the flowers of Erythrina mulungu Mart ex Benth (Leguminosae-Papilionaceae), Epilepsy Behav, 20, 441, 10.1016/j.yebeh.2010.12.037 · doi:10.1016/j.yebeh.2010.12.037
- OA Flausino, 2007, Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety, Biol Pharm Bull, 30, 375, 10.1248/bpb.30.375 · doi:10.1248/bpb.30.375
- OA Flausino, 2007, Anxiolytic effects of erythrinian alkaloids from Erythrina mulungu, J Nat Prod, 70, 48, 10.1021/np060254j · DOI
- D Santos Rosa, 2012, Erysothrine, an alkaloid extracted from flowers of Erythrina mulungu Mart. ex Benth: evaluating its anticonvulsant and anxiolytic potential, Epilepsy Behav, 23, 205, 10.1016/j.yebeh.2012.01.003 · DOI
- S Cheeta, 2001, Antagonism of the anxiolytic effect of nicotine in the dorsal raphe nucleus by dihydro-beta-erythroidine, Pharmacol Biochem Behav, 70, 491, 10.1016/S0091-3057(01)00641-4 · DOI
- SE File, 1998, Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus, Behav Neurosci, 112, 1423, 10.1037/0735-7044.112.6.1423 · doi:10.1037/0735-7044.112.6.1423 · Paper page
- AM Ouagazzal, 1999, Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety, Eur J Neurosci, 11, 3957, 10.1046/j.1460-9568.1999.00823.x · DOI · Paper page
- S Tucci, 2003, Do different mechanisms underlie two anxiogenic effects of systemic nicotine?, Behav Pharmacol, 14, 323, 10.1097/01.fbp.0000081782.35927.c6 · DOI
- P Iturriaga-Vasquez, 2010, Molecular determinants for competitive inhibition of alpha4beta2 nicotinic acetylcholine receptors, Mol Pharmacol, 78, 366, 10.1124/mol.110.065490 · DOI
- JW Daly, 2005, Nicotinic agonists, antagonists, and modulators from natural sources, Cell Mol Neurobiol, 25, 513, 10.1007/s10571-005-3968-4 · DOI · Paper page
- M Alkondon, 1993, Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes, J Pharmacol Exp Ther, 265, 1455, 10.1016/S0022-3565(25)38283-2 · DOI · Paper page
- J Boulter, 1987, Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family, Proc Natl Acad Sci U S A, 84, 7763, 10.1073/pnas.84.21.7763 · DOI · Paper page
- D Goldman, 1987, Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system, Cell, 48, 965, 10.1016/0092-8674(87)90705-7 · DOI · Paper page
- HR Santos, 2006, The magnitude of alpha7 nicotinic receptor currents in rat hippocampal neurons is dependent upon GABAergic activity and depolarization, J Pharmacol Exp Ther, 319, 376, 10.1124/jpet.106.106385 · DOI
- RA Giniatullin, 2000, Rapid relief of block by mecamylamine of neuronal nicotinic acetylcholine receptors of rat chromaffin cells in vitro: an electrophysiological and modeling study, Mol Pharmacol, 58, 778, 10.1124/mol.58.4.778 · DOI
- EM Blumenthal, 1997, Detection of functional nicotinic receptors blocked by alpha-bungarotoxin on PC12 cells and dependence of their expression on post-translational events, J Neurosci, 17, 6094, 10.1523/JNEUROSCI.17-16-06094.1997 · DOI
- K Unna, 1944, Pharmacologic action of Erythrina alkaloids I. Beta-erythroidine and substances derived from it, J Pharmacol Exp Ther, 80, 39, 10.1016/S0022-3565(25)08947-5 · doi:10.1016/s0022-3565(25)08947-5
- K Folkers, 1937, Isolation of erythroidine, an alkaloid of curare action, from Erythrina americana Mill, J Am Chem Soc, 59, 1580, 10.1021/ja01287a509 · DOI
- AJ Lehmann, 1937, Actions of Erythrina americana, a possible curare substitute, J Pharmacol Exp Ther, 60, 69, 10.1016/S0022-3565(25)09848-9 · doi:10.1016/s0022-3565(25)09848-9
- K Unna, 1944, Pharmacologic action of Erythrina alkaloids II. Free, liberated and combined alkaloids, J Pharmacol Exp Ther, 80, 53, 10.1016/S0022-3565(25)08948-7 · doi:10.1016/s0022-3565(25)08948-7
- MW Decker, 1995, Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors, Eur J Pharmacol, 280, 79, 10.1016/0014-2999(95)00191-M · DOI
- X Liu, 2007, Reinforcement enhancing effect of nicotine and its attenuation by nicotinic antagonists in rats, Psychopharmacology (Berl), 194, 463, 10.1007/s00213-007-0863-3 · DOI
- SS Watkins, 1999, Blockade of nicotine self-administration with nicotinic antagonists in rats, Pharmacol Biochem Behav, 62, 743, 10.1016/S0091-3057(98)00226-3 · DOI · Paper page
- MD Ribeiro, 2006, Effect of Erythrina velutina and Erythrina mulungu in rats submitted to animal models of anxiety and depression, Braz J Med Biol Res, 39, 263, 10.1590/S0100-879X2006000200013 · doi:10.1590/s0100-879x2006000200013
- SMM Vasconcelos, 2004, Central activity of hydroalcoholic extracts from Erythrina velutina and Erythrina mulungu in mice, J Pharm Pharmacol, 56, 389, 10.1211/0022357022746 · doi:10.1211/0022357022746
- SA Tucci, 2003, Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors, Neuropharmacol, 44, 367, 10.1016/S0028-3908(02)00391-X · DOI
- MR Zarrindast, 2012, Involvement of rat dopaminergic system of nucleus accumbens in nicotine-induced anxiogenic-like behaviors, Brain Res, 1460, 25, 10.1016/j.brainres.2012.04.036 · DOI
- SE File, 2002, Conditioned anxiety to nicotine, Psychopharmacology (Berl), 164, 309, 10.1007/s00213-002-1219-7 · DOI
- S Tucci, 2002, Anxiety conditioned to nicotine in the elevated plus-maze is time dependent, Behav Pharmacol, 13, 615, 10.1097/00008877-200212000-00002 · DOI · Paper page
- AB Tekinay, 2009, A role for LYNX2 in anxiety-related behavior, Proc Natl Acad Sci U S A, 106, 4477, 10.1073/pnas.0813109106 · DOI · Paper page
- PM Lippiello, 2008, TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity, CNS Neurosci Ther, 14, 266, 10.1111/j.1755-5949.2008.00054.x · DOI · Paper page
Cited by
Global patterns in mangrove soil carbon stocks and losses
Atwood, T. B., Connolly, R. M., Almahasheer, H., Carnell, P. E., Duarte, C. M., Ewers Lewis, C. J., Irigoien, X., Kelleway, J. J., Lavery, P. S., Macreadie, P. I., et al. (2017) · Nature Climate Change · doi:10.1038/nclimate3326 · Cited by 706
Martinez-Guryn, K., Hubert, N., Frazier, K., Urlass, S., Musch, M. W., Ojeda, P., Pierre, J. F., Miyoshi, J., Sontag, T. J., Cham, C. M., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.03.011 · Cited by 663
Tenkanen, H., Di Minin, E., Heikinheimo, V., Hausmann, A., Herbst, M., Kajala, L., & Toivonen, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-18007-4 · Cited by 439
Hausmann, A., Toivonen, T., Slotow, R., Tenkanen, H., Moilanen, A., Heikinheimo, V., & Di Minin, E. (2018) · Conservation Letters · doi:10.1111/conl.12343 · Cited by 403
Oteros-Rozas, E., Martín-López, B., Fagerholm, N., Bieling, C., & Plieninger, T. (2018) · Ecological Indicators · doi:10.1016/j.ecolind.2017.02.009 · Cited by 400
Metadata
- Authors
- Setti-Perdigão, P., Serrano, M. A. R., Flausino, O. A., Bolzani, V. S., Guimarães, M. Z. P., & Castro, N. G.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-12-13
- Volume
- 8
- Issue
- 12
- Pages
- e82726
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1982848477
- Cited by
- 125
- References
- 7
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.